Advertisement
Advertisement

ZYME

ZYME logo

Zymeworks Inc.

24.30
USD
Sponsored
+0.42
+1.76%
Jun 24, 15:59 UTC -4
Closed
exchange

After-Market

23.59

-0.71
-2.92%

ZYME Earnings Reports

Positive Surprise Ratio

ZYME beat 23 of 36 last estimates.

64%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$21.15M
/
-$0.40
Implied change from Q1 26 (Revenue/ EPS)
+778.20%
/
-32.20%
Implied change from Q2 25 (Revenue/ EPS)
-56.60%
/
-1433.33%

Zymeworks Inc. earnings per share and revenue

On May 07, 2026, ZYME reported earnings of -0.59 USD per share (EPS) for Q1 26, missing the estimate of -0.19 USD, resulting in a -201.33% surprise. Revenue reached 2.41 million, compared to an expected 16.59 million, with a -85.48% difference. The market reacted with a -10.19% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 8 analysts forecast an EPS of -0.40 USD, with revenue projected to reach 21.15 million USD, implying an decrease of -32.20% EPS, and increase of 778.20% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
logo
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Zymeworks Inc. reported EPS of -$0.59, missing estimates by -201.33%, and revenue of $2.41M, -85.48% below expectations.
The stock price moved down -10.19%, changed from $26.60 before the earnings release to $23.89 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 8 analysts, Zymeworks Inc. is expected to report EPS of -$0.40 and revenue of $21.15M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement